B-cell activating factor receptor (BAFF-R) chimeric antigen receptor (CAR) T-cell therapy incited cytotoxic effects on both ...

Recall germinal centers formed in response to a secondary infection generate a second line of defense, rebuffing memory B ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the completion of the acquisition of ...

BHUBANESWAR: Ananta Mahakud had always envisioned a bright future for his only daughter Truptimayee. His dreams came crashing ...

The company plans to use the Series B investment to advance the development of its macrophage therapies in inflammatory and ...

A 57-year-old woman with a 12-h history of fever and severe pain in her back, pelvis, and thighs attended our hospital. 24 h ...

Clinical trial results from St. Jude Children's Research Hospital demonstrate benefits to using genomics and early treatment ...

AstraZeneca’s supplemental New Drug Application (sNDA) for CALQUENCE ® (acalabrutinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with previously ...

Resolution Therapeutics Ltd. is preparing for a phase I/II trial of its autologous engineered macrophage cell therapy, RTX-001, in the treatment of end-stage liver disease and has raised £63.5 million ...

During a Case-Based Roundtable® event, Matthew A. Lunning, DO, discussed the updated trial data for 2 chimeric antigen ...

The Liberal and Green Parties both tackled improving cell service in announcements Tuesday, but for different reasons. Meanwhile, the Progressive Conservatives threatened to sue the federal government ...

Several of the new FCEVs are anticipated to support J.B. Hunt Intermodal operations in California and will primarily be used ...